Nilutamide Production Cost Reports

The report provides a detailed analysis essential for establishing a nilutamide production plant. It encompasses all critical aspects necessary for nilutamide production, including the cost of nilutamide production, nilutamide plant cost, nilutamide production costs, and the overall nilutamide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a nilutamide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Nilutamide is a nonsteroidal antiandrogen (NSAA) medication that is used to treat metastatic prostate cancer. It works by blocking androgen receptors and preventing testosterone and dihydrotestosterone from stimulating tumour growth. It is combined with androgen deprivation therapy (ADT), like orchiectomy or GnRH analogues, for combined androgen blockade (CAB). It is paired with orchiectomy to improve progression-free survival, overall survival, objective response rates, and clinical benefits compared to placebo. It is administered orally at 300 mg/day for the first 4 weeks, then 150 mg/day. Meta-analyses show benefits in response rates with comparable tolerability to placebo. Its common side effects include nausea, vomiting, and visual disturbances.

The market for nilutamide is driven by the rising global incidence of prostate cancer. The ageing population, with increasing susceptibility and heightened awareness of early detection, contributes to its demand. The industrial nilutamide procurement is influenced by high raw material costs for key intermediates like 3-trifluoromethyl-4-cyanochlorobenzene, along with regulatory compliance for antiandrogen generics post-patent expiry. Other factors like supply chain vulnerabilities from reliance on specialised chemical suppliers and pricing pressures from competitors like enzalutamide impact its sourcing strategies. The opportunities in cost-effective localised production amid incentives for domestic production further affect its market dynamics.

Raw Material for Nilutamide Production

According to the nilutamide production plant project report, the key raw materials used in the production of nilutamide include 3-trifluoromethyl-4-cyanochlorobenzene, 5,5-dimethylhydantoin, potassium iodide, and potassium hydroxide.

Production Process of Nilutamide

The extensive nilutamide production cost report consists of the following major industrial production process:

1. By nucleophilic aromatic substitution: The production process of nilutamide involves a nucleophilic aromatic substitution. In this process, 5,5-dimethylhydantoin reacts with 3-trifluoromethyl-4-cyanochlorobenzene in dimethyl sulfoxide (DMSO) solvent. This takes place under basic conditions and potassium iodide catalysis. The reaction mixture is cooled, poured into water, and filtered to isolate the crude yellow solid. This is purified by recrystallisation from ethanol or toluene to yield pure nilutamide.

Nilutamide is a synthetic nonsteroidal antiandrogen drug that appears as a white to practically white microcrystalline powder. It has a molecular formula of C₁₂H₁₀F₃N₃O₄ and a molecular weight of 317.22 g/mol. It has a melting point of around 154 degree Celsius. It shows high lipophilicity with a logP value of 4.0, which contributes to its good oral absorption and membrane permeability. It is freely soluble in organic solvents such as ethyl acetate, acetone, chloroform, dichloromethane, ethanol, and methanol. It has very low water solubility, making it suitable for tablet formulations with stability under standard storage conditions.